The lack of effect of progestogen on bone

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 44, Issue 2 SUPPL., 1999, Pages 215-220

  Lindsay, Robert ^a  

^a HELEN HAYES HOSPITAL   (United States)

Author keywords

Bone mineral density; Hormone replacement therapy, post menopausal; Progestogens

Indexed keywords

ESTROGEN; GESTAGEN;

BONE STRENGTH; BONE TURNOVER; CONFERENCE PAPER; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL;

AGED; BONE DENSITY; BONE RESORPTION; ESTROGENS; FEMALE; HOMEOSTASIS; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; OSTEOPOROSIS; POSTMENOPAUSE; PROGESTINS;

EID: 0033013050     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Prior JC, Vigna YM, Barr SI, et al: Ovulatory premenopausal women lose cancellous spinal bone: A five year prospective study. Bone 1996;18:261-267
2. Prior JC, Vigna YM, Barr SI, et al: Cyclic medroxyprogesterone treatment increases bone density: A controlled trial in active women with menstrual cycle disturbances. Am J Med 1994;96:521-530
3. Waller K, Reim J, Fenster L, et al: Bone mass and subtle abnormalities in ovulatory function in healthy women. J Clin Endocrinol Metab 1996;81:663-668
4. De Souza MJ, Miller BE, Sequenzia LC, et al: Bone health is not affected by luteal phase abnormalities and decreased ovarian progesterone production in female runners. J Clin Endocrinol Metab 1997;82:2867-2876
5. Lau K-HW, Wang SP, Linkhart TA, et al: Picomolar norethindrone in vitro stimulates the cell proliferation and activity of a human osteosarcoma cell line and increases bone collagen synthesis without an effect on bone resorption. J Bone Miner Res 1994;9:695-703
6. Takada J, Baylink DJ, Lau KH: Pretreatment with low doses of norethindrone potentiates the osteogenic effects of fluoride on human osteosarcoma cells. J Bone Miner Res 1995;10: 1512-1522
7. Lindsay R, Hart DM, Purdie D, et al: Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women. Clin Sci Mol Med 1978;54:193-195
8. Mandel FP, Davidson BJ, Erlik Y, et al: Effects of progestins on bone metabolism in postmenopausal women. J Reprod Med (suppl) 1982;27:511-514
9. Cundy T, Evans M, Roberts H, et al: Bone density in women receiving depot medroxyprogesterone acetate for contraception. Br Med J 1991;27:13-16
10. Gallagher JC, Kable WT, Goldgar D: Effect of progestin therapy on cortical and trabecular bone: Comparison with estrogen. Am J Med 1991;90:171-178
11. Jayo MJ, Register TC, Carlson CS: Effects on bone of oral hormone replacement therapy initiated 2 years after ovariectomy in young adult monkeys. Bone 1998;23:361-366
12. Pors Nielsen S, Bärenholdt O, Hermansen F, et al: Magnitude and pattern of skeletal response to long term continuous and cyclic sequential oestrogen/progestin treatment. Br J Obstet Gynaecol 1994;101:319-324
13. The Writing Group for the PEPI Trial: Effects of hormone therapy on bone mineral density: Results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA 1996;276:1389-1396
14. Christiansen C, Riis BJ: Five years with continuous combined oestrogen/progestogen therapy: Effects on calcium metabolism, lipoproteins, and bleeding pattern. Br J Obstet Gynaecol 1990;97:1087-1092
15. Speroff L, Rowan J, Symons J, et al: The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study): A randomized controlled trial. JAMA 1996;276:1397-1403
16. Studd JW, Holland EF, Leather AT, et al: The dose-response of percutaneous oestradiol implants on the skeletons of postmenopausal women. Br J Obstet Gynaecol 1994;101:787-791
17. Savvas M, Studd JW, Norman S, et al: Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in postmenopausal women who have previously received long-term oral oestrogens. Br J Obstet Gynaecol 1992;99:757-760
18. Holland EF, Chow JW, Studd JW, et al: Histomorphometric changes in the skeleton of postmenopausal women with low bone mineral density treated with percutaneous estradiol implants. Obstet Gynecol 1994;83:387-391
19. Holland EF, Studd JW, Mansell JP, et al: Changes in collagen composition and cross-links in bone and skin of osteoporotic postmenopausal women treated with percutaneous estradiol implants. Obstet Gynecol 1994;83:180-183
20. Holland EF, Leather AT, Studd JW: The effect of 25-mg percutaneous estradiol implants on the bone mass of postmenopausal women. Obstet Gynecol 1994;83:43-46
21. Lippuner K, Haenggi W, Birkhaeuser MH, et al: Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with the 17β-estradiol and dydrogesterone. J Bone Miner Res 1997;12:806-812